Decoy Therapeutics Inc. DCOY 深 滬
等待開盤 05-23 09:30:00 美东时间
7.30
+0.870
+13.53%
華盛通- 最 高7.30
- 今 開6.43
- 成交量 1.06万股
- 最 低 6.43
- 昨 收 6.43
- 總市值 388.34万
- 52周最高 415.80
- 市盈率 靜 --
- 換手率 1.99%
- 52周最低 4.3201
- 委 比 20.48%
- 總股本 53.20万
- 歷史最高 533340.00
- 量 比 0.74
- 振 幅 13.53%
- 歷史最低 6.1776
- 每 手 1
- 風險率 54.48%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Decoy Therapeutics Sets 2026 Annual Shareholder Meeting Date
Decoy Therapeutics ( ($DCOY) ) has issued an announcement. On May 12, 2026, Dec...
05-20 04:42
Decoy Therapeutics Q1 EPS $(4.18) Misses $(4.08) Estimate
Decoy Therapeutics (NASDAQ:DCOY) reported quarterly losses of $(4.18) per share which missed the analyst consensus estimate of $(4.08) by 2.45 percent. This is a 98.26 percent increase over losses of $(240.07) per share
05-09 06:16
Decoy Therapeutics to Present at Two Peptide Therapeutics Conferences in Boston
CBO Peter Marschel to Lead HubXchange Roundtable on Computational Peptide Design CSO Dr. Barbara Hibner and CTO Dr. Michael Lipp to Co-Present at Peptide-Based Therapeutics Summit; Advisor D...
04-27 20:45
Decoy Therapeutics to present at virtual investor Closing Bell event
Decoy Therapeutics to present at virtual investor Closing Bell event Decoy Therapeutics to participate in Virtual Investor Closing Bell webcast on April 9, 2026 at 4:00 p.m. ET. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT
04-09 20:36
Decoy Therapeutics Regains Nasdaq Compliance
Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), announces that on March 31, 2026 the Company received notification from the Nasdaq Stock Market LLC that it has regained compliance with Listing Rule
04-02 21:05
Decoy Therapeutics shares are trading lower after the company announced a 1-for-12 reverse stock split.
Decoy Therapeutics shares are trading lower after the company announced a 1-for...
03-06 01:25
Decoy Therapeutics Announces 1‑For‑12 Reverse Stock Split Effective March 6
Decoy Therapeutics Inc. (NASDAQ:DCOY), a preclinical-stage biopharmaceutical company that is engineering the next generation of peptide conjugate therapeutics, today announced that it will effect a 1-for-12 reverse stock
03-05 21:39
Decoy Therapeutics Announces 1-for-12 Reverse Stock Split
CAMBRIDGE, Mass., March 5, 2026 /PRNewswire/ -- Decoy Therapeutics Inc. (NASDAQ: DCOY), a preclinical-stage biopharmaceutical company that is engineering the next generation of peptide conju...
03-05 21:30
Decoy Therapeutics Joins Webull Corporate Connect Service Platform
- Connect with the Company on Webull here CAMBRIDGE, Mass. and HOUSTON, Feb. 11, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), a preclinical biopharm...
02-11 22:00
美股大行评级 | 英特尔绩后获多家大行上调目标价；理想汽车、Mobileye、Meta、微软、甲骨文等遭下调目标价
今日重点评级关注：RBC Capital：维持Compass Pathways"跑赢大市"评级，目标价从16美元升至21美元；RBC Capital：维持GH Research"跑赢大市"评级，目标价从33美元升至40美元
01-26 14:32
